Hsp70 cochaperone BAG3-mediated Autophagy Activation for Synaptic Protein Quality Control

Target: BAG3 (Bcl-2-associated athanogene 3) Composite Score: 0.447 Price: $0.45▼5.1% Citation Quality: Pending proteomics Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
⚠ Missing Evidence⚠ Thin Description⚠ Low Validation Senate Quality Gates →
Evidence Strength Pending (0%)
0
Citations
1
Debates
5
Supporting
6
Opposing
Quality Report Card click to collapse
C
Composite: 0.447
Top 79% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.55 Top 68%
C Evidence Strength 15% 0.47 Top 70%
B Novelty 12% 0.65 Top 55%
C Feasibility 12% 0.40 Top 84%
C+ Impact 12% 0.55 Top 77%
D Druggability 10% 0.35 Top 87%
C Safety Profile 8% 0.40 Top 83%
C Competition 6% 0.40 Top 92%
C Data Availability 5% 0.45 Top 84%
C+ Reproducibility 5% 0.50 Top 63%
Evidence
5 supporting | 6 opposing
Citation quality: 0%
Debates
1 session C+
Avg quality: 0.50
Convergence
0.00 F 15 related hypothesis share this target

From Analysis:

Quantitative proteomics of the aging synapse: protein turnover and aggregation in neurodegeneration

How does synaptic protein turnover change with age and neurodegeneration, and what role does impaired protein homeostasis play in synaptic dysfunction? Specifically, how do ubiquitin-proteasome and autophagy-lysosome pathways fail in aging synapses, leading to accumulation of misfolded proteins and synaptic degeneration in Alzheimer's and related dementias?

→ View full analysis & debate transcript

Description

Hsp70 cochaperone BAG3-mediated Autophagy Activation for Synaptic Protein Quality Control

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["Synaptic Protein Misfolding
Age-related aggregation"] B["Hsc70 Chaperone
Client Substrate Binding"] C["BAG3 Cochaperone
Hsc70 ATPase regulation"] D["p62/SQSTM1 Bridging
Autophagy receptor recruitment"] E["LC3-II Interaction
Autophagosome membrane"] F["Selective Macroautophagy
Chaperone-assisted"] G["Lysosomal Degradation
Aggregate clearance"] H["Synaptic Proteostasis
Neuroprotection"] A --> B B --> C C --> D D --> E E --> F F --> G G --> H style C fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7 style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

GTEx v10 Brain Expression

JSON

Median TPM across 13 brain regions for BAG3 (Bcl-2-associated athanogene 3) from GTEx v10.

Cerebellum93.7 Cerebellar Hemisphere78.9 Caudate basal ganglia46.5 Putamen basal ganglia41.8 Nucleus accumbens basal ganglia40.7 Substantia nigra38.6 Hypothalamus36.9 Amygdala35.8 Spinal cord cervical c-131.5 Cortex26.8 Anterior cingulate cortex BA2426.6 Hippocampus23.9 Frontal Cortex BA922.8median TPM (GTEx v10)

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.55 (15%) Evidence 0.47 (15%) Novelty 0.65 (12%) Feasibility 0.40 (12%) Impact 0.55 (12%) Druggability 0.35 (10%) Safety 0.40 (8%) Competition 0.40 (6%) Data Avail. 0.45 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.447 composite
11 citations 11 with PMID Validation: 0% 5 supporting / 6 opposing
For (5)
No supporting evidence
No opposing evidence
(6) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
10
1
MECH 10CLIN 0GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
BAG3 overexpression enhances clearance of ubiquiti…SupportingMECH----PMID:24662967-
BAG3 directly interacts with p62/SQSTM1 to bridge …SupportingMECH----PMID:26364927-
BAG3 expression decreases with aging in neurons an…SupportingMECH----PMID:29999487-
p62/SQSTM1 accumulates in AD synapses, suggesting …SupportingMECH----PMID:30401736-
BAG3-Hsc70-p62 axis directs substrates from protea…SupportingMECH----PMID:26364927-
BAG3 is primarily a stress-response protein - elev…OpposingMECH----PMID:26240158-
Forced BAG3 overexpression causes Hsc70 sequestrat…OpposingMECH----PMID:26240158-
BAG3 implicated in propagating tau pathology throu…OpposingMECH----PMID:31988307-
p62 accumulation IS pathological - p62-positive in…OpposingMECH----PMID:24456934-
p62 knockout reduces tau aggregation - p62 is path…OpposingGENE----PMID:24456934-
p62 accumulates in AD synapses because lysosomal d…OpposingMECH----PMID:30401736-
Legacy Card View — expandable citation cards

Supporting Evidence 5

BAG3 overexpression enhances clearance of ubiquitinated aggregates via selective autophagy
BAG3 directly interacts with p62/SQSTM1 to bridge Hsc70 clients to autophagosomes
BAG3 expression decreases with aging in neurons and in AD brain tissue
p62/SQSTM1 accumulates in AD synapses, suggesting upstream autophagy receptor saturation
BAG3-Hsc70-p62 axis directs substrates from proteasome to autophagy

Opposing Evidence 6

BAG3 is primarily a stress-response protein - elevating in non-stressed synapses may be counterproductive
Forced BAG3 overexpression causes Hsc70 sequestration, impairing general proteostasis
BAG3 implicated in propagating tau pathology through exosome secretion
p62 accumulation IS pathological - p62-positive inclusions are diagnostic of NBD and seen in ALS/FTLD
p62 knockout reduces tau aggregation - p62 is pathological, not therapeutic
p62 accumulates in AD synapses because lysosomal degradation is impaired - enhancing BAG3 won't fix lysosomes
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-18 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Therapeutic Hypotheses: Synaptic Protein Turnover in Aging & Neurodegeneration

Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses

Title: Small-molecule TFEB activation to overcome autophagosome-lysosome fusion deficits in Alzheimer's synapses

Description: The transcription factor EB (TFEB) is the master regulator of lysosomal biogenesis and autophagy gene expression. In aging neurons and Alzheimer's disease, TFEB nuclear translocation is impaired due to mTOR overactivation and impaired calcium signaling. Pharmacological TFEB activation using r

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Synaptic Proteostasis Therapeutic Hypotheses

Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis

Weaknesses in Evidence

1. Pleiotropic transcriptional effects
TFEB regulates hundreds of genes beyond lysosomal biogenesis, including lipid metabolism genes (PPARG, PLIN2), inflammatory pathways, and extracellular matrix remodeling genes. The literature cited (PMID: 25661182) shows cellular model validation, but these systems lack the complexity of aged human synapses where off-target transcriptional programs could dysregulate synaptic transmission

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Drug Development Feasibility Analysis: Synaptic Proteostasis Hypotheses

Executive Summary

All seven hypotheses target mechanistically plausible nodes in synaptic proteostasis, but face significant translational barriers. The fundamental challenge is that proteostasis networks are highly interconnected—single-node interventions trigger compensatory responses that may negate therapeutic benefit. The revised confidence scores in the skeptic critique are scientifically justified: mean original confidence (0.64) drops to 0.40 after critique, reflecting legitimate concerns about compound sp

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.430.450.47 0.49 0.41 2026-04-252026-04-272026-04-28 Market PriceScoreevidencedebate 8 events
7d Trend
Falling
7d Momentum
▼ 5.1%
Volatility
Medium
0.0286
Events (7d)
8

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (7)

No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
0

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.497

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for BAG3 (Bcl-2-associated athanogene 3).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for BAG3 (Bcl-2-associated athanogene 3) →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

KG Entities (39)

19S_proteasomeAD_brainAD_hippocampusAD_synapsesAD_temporal_cortexAPPAβ_oligomersBAG3CHIP/STUB1Cathepsin_DHsp70Neuronal_Ceroid_LipofuscinosisTFEBTFEB_Ser211USP14V-ATPaseVPS35aged_brainaged_neuronsaging_neurons

Related Hypotheses

TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses
Score: 0.591 | proteomics
VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking
Score: 0.525 | proteomics
TFEB Activation to Restore Lysosomal Biogenesis in Alzheimer's Disease Neuronal Networks
Score: 0.523 | proteomics
TFEB-Mediated Retromer Biogenesis to Restore Endosomal-Lysosomal Trafficking in Aged Synapses
Score: 0.510 | proteomics
USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Substrates
Score: 0.486 | proteomics

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions (2)

2 total 0 confirmed 0 falsified
IF BAG3 is knocked down in mature hippocampal neurons (DIV14) via lentiviral CRISPR/Cas9 editing targeting BAG3 exons 2-3, THEN synaptic autophagy flux will be significantly reduced (measured by decreased colocalization of LC3-II puncta with synaptic markers bassoon and vGLUT1) AND ubiquitinated protein aggregates will accumulate at synaptic terminals (measured by biochemical fractionation and Western blot) within 14 days.
pending conf: 0.67
Expected outcome: Expected ≥40% reduction in synaptic LC3-II puncta per bassoon-positive terminal and ≥30% increase in synaptic ubiquitin signal density compared to scrambled guide RNA controls
Falsified by: Synaptic LC3-II puncta density and autophagic flux markers remain within 1 standard deviation of control levels, or ubiquitinated protein aggregates do not accumulate at synapses despite confirmed BAG3 knockdown efficiency >70%
Method: Primary rat hippocampal neuron cultures (E18) transduced with BAG3-targeting CRISPR Lentivector (Sigma) with validated knockdown efficiency, high-content confocal imaging (Zeiss LSM 880) of LC3-II puncta in synaptic compartments defined by bassoon (Synaptic Systems #141 011) and vGLUT1 (SYSY #135 311) immunostaining, synaptic-terminal fractionation via synaptoneurosome preparation
IF BAG3 is selectively overexpressed at synapses using AAV9-Synapsin-BAG3-mCherry stereotactically injected into bilateral hippocampus of 3xTg-AD mice at 6 months of age, THEN synaptic autophagy markers will increase (elevated LC3-II/LC3-I ratio in synaptoneurosome fractions) AND phosphorylated tau accumulation at synapses will be reduced (decreased AT8 immunoreactivity in synaptic fractions) compared to AAV9-Synapsin-mCherry control-injected 3xTg-AD mice within 8 weeks.
pending conf: 0.58
Expected outcome: Expected ≥50% increase in synaptic LC3-II/LC3-I ratio and ≥35% reduction in synaptic AT8 (pS202/pT208) signal normalized to synaptic PSD-95 in BAG3-overexpressing mice versus controls
Falsified by: Synaptic LC3-II/LC3-I ratio shows no significant change (remains within 1 SD of control) or synaptic tau pathology (AT8, MC1) does not decrease despite confirmed BAG3 overexpression (mCherry fluorescence and Western blot) in hippocampal synaptic fractions
Method: C57BL/6J;129×1/SvJ 3xTg-AD mice (RRID:IMSR_JAX:006190) receiving bilateral hippocampal AAV9-Synapsin-hBAG3-mCherry injections (1.5e13 gc/mL, 500nL per site), synaptoneurosome preparation at 8 weeks post-injection, immunoblot for LC3 (Cell Signaling #2775), AT8 (Thermo #MN1020), PSD-95 (NeuroMab #75-028), and tau (DAKO #A0024)

Knowledge Subgraph (29 edges)

accumulate at (1)

autophagosomespresynaptic_terminals

accumulates at (2)

Aβ_oligomerssynaptic_terminalsphosphorylated_tausynaptic_terminals

accumulates in (2)

ubiquitinated_proteinsAD_hippocampusp62AD_synapses

activates (1)

Cathepsin_Dalpha_synuclein_fibrillization

associated with (1)

USP1419S_proteasome

cooperates with (1)

Hsp70CHIP/STUB1

decreased expression in (1)

BAG3aged_neurons

deficiency causes (1)

Cathepsin_DNeuronal_Ceroid_Lipofuscinosis

hyperactive in (1)

mTORAD_brain

interacts with (1)

BAG3p62/SQSTM1

less acidic in (1)

lysosomal_pHaging_neurons

limited trafficking to (1)

lysosomesdistal_axons

mediates retrieval of (1)

VPS35APP

mislocalized to (1)

APPendosomes

mutations cause (1)

VPS35familial_Parkinson's_disease

phosphorylates (1)

mTORTFEB_Ser211

recruits Hsc70 clients to (1)

BAG3autophagosomes

redirected to (1)

APPamyloidogenic_compartments

reduced activity in (1)

Cathepsin_Daged_brain

reduced in (1)

VPS35AD_hippocampus

reduced levels in (1)

CHIP/STUB1AD_temporal_cortex

removes ubiquitin from (1)

USP14proteasome_substrates

transcription factor regulates (3)

TFEBlysosomal_biogenesisTFEBV-ATPaseTFEBcathepsins

ubiquitinates (2)

CHIP/STUB1phosphorylated_tauCHIP/STUB1mutant_APP

Mechanism Pathway for BAG3 (Bcl-2-associated athanogene 3)

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    TFEB["TFEB"] -->|transcription fact| lysosomal_biogenesis["lysosomal_biogenesis"]
    TFEB_1["TFEB"] -->|transcription fact| V_ATPase["V-ATPase"]
    TFEB_2["TFEB"] -->|transcription fact| cathepsins["cathepsins"]
    mTOR["mTOR"] -->|hyperactive in| AD_brain["AD_brain"]
    mTOR_3["mTOR"] -->|phosphorylates| TFEB_Ser211["TFEB_Ser211"]
    A__oligomers["Aβ_oligomers"] -->|accumulates at| synaptic_terminals["synaptic_terminals"]
    phosphorylated_tau["phosphorylated_tau"] -->|accumulates at| synaptic_terminals_4["synaptic_terminals"]
    USP14["USP14"] -->|associated with| n19S_proteasome["19S_proteasome"]
    USP14_5["USP14"] -->|removes ubiquitin| proteasome_substrates["proteasome_substrates"]
    ubiquitinated_proteins["ubiquitinated_proteins"] -->|accumulates in| AD_hippocampus["AD_hippocampus"]
    BAG3["BAG3"] -->|interacts with| p62_SQSTM1["p62/SQSTM1"]
    BAG3_6["BAG3"] -->|recruits Hsc70 cli| autophagosomes["autophagosomes"]
    style TFEB fill:#ce93d8,stroke:#333,color:#000
    style lysosomal_biogenesis fill:#4fc3f7,stroke:#333,color:#000
    style TFEB_1 fill:#ce93d8,stroke:#333,color:#000
    style V_ATPase fill:#ce93d8,stroke:#333,color:#000
    style TFEB_2 fill:#ce93d8,stroke:#333,color:#000
    style cathepsins fill:#ce93d8,stroke:#333,color:#000
    style mTOR fill:#ce93d8,stroke:#333,color:#000
    style AD_brain fill:#4fc3f7,stroke:#333,color:#000
    style mTOR_3 fill:#ce93d8,stroke:#333,color:#000
    style TFEB_Ser211 fill:#4fc3f7,stroke:#333,color:#000
    style A__oligomers fill:#4fc3f7,stroke:#333,color:#000
    style synaptic_terminals fill:#4fc3f7,stroke:#333,color:#000
    style phosphorylated_tau fill:#4fc3f7,stroke:#333,color:#000
    style synaptic_terminals_4 fill:#4fc3f7,stroke:#333,color:#000
    style USP14 fill:#ce93d8,stroke:#333,color:#000
    style n19S_proteasome fill:#4fc3f7,stroke:#333,color:#000
    style USP14_5 fill:#ce93d8,stroke:#333,color:#000
    style proteasome_substrates fill:#4fc3f7,stroke:#333,color:#000
    style ubiquitinated_proteins fill:#4fc3f7,stroke:#333,color:#000
    style AD_hippocampus fill:#4fc3f7,stroke:#333,color:#000
    style BAG3 fill:#ce93d8,stroke:#333,color:#000
    style p62_SQSTM1 fill:#ce93d8,stroke:#333,color:#000
    style BAG3_6 fill:#ce93d8,stroke:#333,color:#000
    style autophagosomes fill:#ce93d8,stroke:#333,color:#000

3D Protein Structure

🧬 BAG3 — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for BAG3 structures...
Querying Protein Data Bank API

Source Analysis

Quantitative proteomics of the aging synapse: protein turnover and aggregation in neurodegeneration

proteomics | 2026-04-16 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (5)

TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses
Score: 0.59 · TFEB (TFE3, TFE4 family)
VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking
Score: 0.52 · VPS35 (VPS26/VPS29/VPS35 complex)
TFEB Activation to Restore Lysosomal Biogenesis in Alzheimer's Disease
Score: 0.52 · TFEB
TFEB-Mediated Retromer Biogenesis to Restore Endosomal-Lysosomal Traff
Score: 0.51 · TFEB
USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Sub
Score: 0.49 · USP14 (ubiquitin-specific peptidase 14)
→ View all analysis hypotheses
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.